• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA CH ENZYMATIC CREATININE_2 (ECRE_2); ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA CH ENZYMATIC CREATININE_2 (ECRE_2); ENZYMATIC METHOD, CREATININE Back to Search Results
Model Number N/A
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/02/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Additional information (05-jun-2025): siemens service operations support (sos) concluded the investigation of the event.Sos reviewed the information provided by the customer and the data from the instrument.No reagent or instrument issues were identified.The customer ran quality control (qc) after processing the samples, which was out of range, low.Review of the calibration data showed low recovery for the calibrator.Calibration was performed as a standard troubleshooting procedure.Qc recovery was within the customer¿s expected ranges after the new calibration.The cause of the event is unknown.A potential product issue was not identified.The customer is operational.The device is performing within specifications.No further evaluation is required.In section h6, the investigation finding and investigation conclusion codes were updated.Initial mdr 2432235-2025-00135 was filed on 20-may-2025.
 
Additional Manufacturer Narrative
A united states (us) customer contacted the siemens healthcare diagnostics remote services center (rsc) regarding erroneously depressed (below the measuring interval) creatinine_2 (crea_2) results obtained on an atellica ch 930 analyzer.Siemens is investigating the event.
 
Event or Problem Description
The customer reported to siemens they obtained erroneously depressed (below the measuring interval) creatinine_2 (crea_2) patient sample results on an atellica ch 930 analyzer.The erroneously depressed patient.Results were not reported to the physician(s).The same samples were reprocessed on an alternate atellica ch 930 analyzer.Higher results obtained, considered correct and reported to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the erroneously depressed creatinine_2 (crea_2) results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA CH ENZYMATIC CREATININE_2 (ECRE_2)
Common Device Name
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
500 gbc drive po box 6101
registration # 2517506
newark DE 19714 6101
Manufacturer Contact
eiman sulieman
500 gbc drive
po box 6101
newark, DE 19714-6101
7372808688
MDR Report Key22053049
Report Number2432235-2025-00135
Device Sequence Number20169229
Product Code JFY
UDI-Device Identifier00630414596457
UDI-Public(01)00630414596457(10)242278(17)250901
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/01/2025
Device Model NumberN/A
Device Catalogue Number11097596
Device Lot Number242278
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/03/2025
Supplement Date Received by Manufacturer06/05/2025
Initial Report FDA Received Date05/20/2025
Supplement Report FDA Received Date06/24/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-